Spontaneous muscle hematoma in patients with COVID-19: Experience of 3 cases
The overall bleeding complication rate in patients receiving anticoagulation, whether in COVID-19 or non-COVID-19 patients is low, only slightly higher in critically ill patients and those receiving a therapeutic dose of anticoagulants. Among bleeding complications, spontaneous muscle hematomas (SMH) are particularly uncommon, often overlooked or misdiagnosed.
Spontaneous muscle hematoma in patients with COVID-19: Experience of 3 cases Read More »